Novavax Inc. buy BTIG Research
Start price
28.02.25
/
50%
€6.81
Target price
28.02.26
€18.25
Performance (%)
22.38%
End price
01.03.26
€8.34
Summary
This prediction ended on 01.03.26 with a price of €8.34. The prediction had a final performance of 22.38%. BTIG_Research has a follow-up prediction for Novavax Inc. where he still thinks Novavax Inc. is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | 2.899% | 2.899% | 25.864% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by BTIG_Research for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
In the thread Trading Novavax Inc.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten